COVID-19 – You Are Safe in Our Care. The hospital, emergency department, urgent care, physician offices and virtual clinics are open to safely deliver care.

SATURN

Statins use in intracerebral hemorrhage patients.

Objective

This is a study involving participants who have been on a stable regimen of statins, a class of medications used to lower cholesterol levels, who have been admitted to the hospital with intracerebral hemorrhage (ICH). ICH is a type of bleeding that occurs around the brain. It has been proposed that the use of statins may increase the risk of ICH recurrence, and genetics may also play a role in this. This study is a multi-center, randomized trial that will compare continuing the use of statins versus discontinuation of statins and how this may affect the likelihood of ICH happening again. A genetic marker will also be analyzed to study its effect on ICH recurrence. A total of 1,456 participants will be enrolled in the United States.

Sponsor

  • National Institute of Neurological Disorders and Stroke, a subdivision of the National Institute of Health.

Principal Investigator

Contact